Flow cytometric quantification of cyclin E in human cell lines and hematopoietic malignancies

Cytometry

Volumn 32, Issue 3, 1998, Pages 214-222

  Erlanson, Martin ^a   Landberg, Göran ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cell cycle; Cyclin E; Flow cytometry; Quantification

Indexed keywords

CYCLIN E;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL LINE; CLINICAL ARTICLE; DNA CONTENT; DNA DETERMINATION; FLOW CYTOMETRY; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANTIBODIES; BLOTTING, WESTERN; CELL CYCLE; CYCLIN E; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEMATOLOGIC NEOPLASMS; HUMANS; TUMOR CELLS, CULTURED;

EID: 0032125521     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19980701)32:3<214::AID-CYTO8>3.0.CO;2-J     Document Type: Article

References (44)

1. Aggrawal R, Aggrawal Y, Mäntyjärvi R: Flow cytometric quantitation of C-myc and p53 proteins in bovine papillomavirus type 1-transformed primary mouse fibroblasts. Cytometry 17:237-245, 1994.
2. Brockhoff G, Hofstsaedter F, Knuechel R: Flow cytometric detection and quantitation of the epidermal growth factor receptor in comparison to Scatchard analysis in human bladder carcinoma cell lines. Cytometry 17:75-83, 1994.
3. Brooks SC, Locke ER, Soule HD: Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 248:6251-6253, 1973.
4. Buckley M, Sweeney K, Hamilton J, Sini RL, Manning DL, Nicholson RI, Defazio A, Watts CKW, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogcne 8:2127-2133, 1993.
5. Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganus F: Cytometry of cyclin proteins. Cytometry 25:1-13, 1996.
6. Dawson CD, Schepler JA, Nicholson JKA, Holman RC: Enumeration of antigen sites on cells by FCM. Pathobiology 59:57-61, 1991.
7. Deshaies RJ, Chau V, Kirschner M: Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway. EMBO J 14:303-312, 1995.
8. Dutta A, Chandra R, Leiter L, Lester S: Cyclins as marker of tumor proliferation: Immunocytochemical studies in breast cancer. Proc Natl Acad Sci USA 92:5386-5390, 1995.
9. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE: Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18:522-529, 1965.
10. Gey GO, Coffman WD, Kubieck WT: Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12:264-265, 1952.
11. Gong J, Traganos F, Darzynkiewicz Z: Expression of cyclins B and E in individual Molt-4 cells and in stimulated human lymphocytes during their progression through the cell cycle. Int J Oncol 3:1037-1042, 1993.
12. Gong J, Li X, Traganos F, Darzynkiewicz Z: Expression of G1 and G2 cyclins measured in individual cells by multiparameter FCM: A new tool in the analysis of the cell cycle. Cell Prolif 27:357-371, 1994.
13. Gong J, Ardelt B, Traganus F, Darzynkiewicz Z: Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res 54:4285-4288, 1994.
14. Gong J, Traganos F, Darzynkiewicz Z: Threshold expression of cyclin E but not D type cyclins characterizes normal and tumour cells entering S phase. Cell Prolif 28:337-346, 1995.
15. Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA, Keyomarsi K: Cyclin E, a reductant cyclin in breast cancer. Proc Natl Acad Sci USA 93:15215-15220, 1996.
16. Heremans H, Billiau A, Cassiman JJ, Mulier JC, de Somer P: In vitro cultivation of human tumor tissues. II. Morphological and virological characterization of three cell lines. Oncology 35:246-252, 1978.
17. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006, 1992.
18. Hunter T, Pines J: Cyclins and cancer. Cell 66:1071-1074, 1991.
19. Kaplan J, Tilton J, Peterson WD: Identification of T-cell lymphoma tumor antigens on human T-cell lines. Am J Hematol 1:219-223, 1976.
20. Keyomarsi K, Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90:1112-1116, 1993.
21. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB: Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380-385, 1994.
22. Keyomarsi K, Conte D Jr, Toyofuku W, Fox MP: Deregulation of cyclin E in breast cancer. Oncogene 11:941-950, 1995.
23. Klein E, Klein G, Nadkarni JS, Nadkarni JJ, Wigzell H, Clifford P: Surface IgM kappa specificity on a Burkitt lymphoma cell line in vivo and in derived culture lines. Cancer Res 28:1300-1310, 1968.
24. Klein G, Dombos L: Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome. Int J Cancer 11:327-337, 1973.
25. Landberg G, Roos G: Antibodies to proliferating cell nuclear antigen (PCNA) as S-phase probes in flow cytometric cell cycle analysis. Cancer Res 51:4570-4574, 1991.
26. Landberg G, Roos G: Expression of proliferating cell nuclear antigen (PCNA) and KI-67 antigen in human hematopoietic cells. Acta Oncol 30:917-921, 1991
27. Larsson I, Lundgren E, Nilsson K, Strannegard O: A human neoplastic hematopoietic cell line producing a fibroblast type of interferon. Dev Biol Stand 42:193-197, 1979.
28. Lew DJ, Dulic V, Reed SI: Isolation of three novel human cyclins by rescue of G1 cyclin (Gin) function in yeast. Cell 66:1197-1206, 1991.
29. Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45:321-334, 1975.
30. Minowada J, Ohnuma T, Moore GE: Rosette-forming lymphoid cell lines. I. Establishment and evidence for origin of thymus derived lymphocytes. J Natl Cancer Inst 49:891-895, 1972.
31. Motukura T, Arnold A: Cyclins and ontogenesis. Biochim Biophys Acta 1155:63-78, 1993.
32. Nielsen NH, Arnelöv C, Emdin SO, Landberg G: Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 74:874-880, 1996.
33. Nielsen NH, Emdin SO, Cajander J, Landberg G: Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 14:295-304, 1997.
34. Ohtsubo M, Theodoras A, Schumacher J, Roberts J, Pagano M: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612-2624, 1995.
35. Peter M, Herskowitz I: Joining the complex: Cydin-dependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184, 1994.
36. kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3:222-225, 1997.
37. Pulvertaft RJV: A study of malignant tumours in Nigeria by short term tissue culture. J Clin Pathol 18:261-273, 1965.
38. Resnitzky D, Gossen M, Bujard H, Reed SI: Acceleration of the G1/S phase transition by expression of cyclin D1 and E with an inducible system. Mol Cell Biol 14:1669-1679, 1994.
39. Scuderi R, Palucka KA, Pokrovskaja K, Bjorkholm M, Wiman KG, Pisa P: Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage. Blood 87:3360-3367, 1996.
40. Sundström C, Nilsson K: Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17:565-577, 1976.
41. Vogt RF, Etridge SF, Hendersson LO: Calibrated binding capacity of antibiody-coated microbeads for labeled antibodies against the CD4 surface marker. Cytometry [Suppl] 4:75, 1990.
42. Wolowiec D, Benchaib M, Pernas P, Deviller P, Soucher C, Rimokh R, Felman P, Bryon PA, Ffrench M: Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia 9:1382-1388, 1995.
43. Won K-A, Reed SI: Activation of cyclin E/CDK is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J 15:4182-4193, 1996.
44. Zukerberg LR, Benedict WF, Arnold A, Dyson N, Harlow E, Harris NL: Expression of the retinoblastoma protein in low-grade B-cell lymphoma: Relationship to cyclin D1. Blood 88:268-276, 1996.